Delivery of steroids into the eye for the treatment of macular edema.

about

Carriers for the tunable release of therapeutics: etymological classification and examples.Dexamethasone implant (0.7 mg) in Indian patients with macular edema: Real-life scenario

P2860

Q30367806-F340250A-25E7-44C7-8355-AC2A8FE9425D Q57193051-751B4681-B153-4722-9BB7-8BD790053F00

P2860

Delivery of steroids into the eye for the treatment of macular edema.

Item

http://www.wikidata.org/entity/Q38815223

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Delivery of steroids into the eye for the treatment of macular edema.

@en

type

Item

label

Delivery of steroids into the eye for the treatment of macular edema.

@en

prefLabel

Delivery of steroids into the eye for the treatment of macular edema.

@en

P1476

Delivery of steroids into the eye for the treatment of macular edema.

@en

P2093

Amir Hadayer

http://www.w3.org/2001/XMLSchema#string

Shlomit Schaal

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein

Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye

Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.

Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.

How corticosteroids control inflammation: Quintiles Prize Lecture 2005

Pharmacokinetics of ophthalmic corticosteroids.

Association of compounded bevacizumab with postinjection endophthalmitis.

The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates.

P304

1083-1091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17425247.2016.1182488

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27105838

http://www.w3.org/2001/XMLSchema#string

Delivery of steroids into the eye for the treatment of macular edema.

about

P2860

P2860

Delivery of steroids into the eye for the treatment of macular edema.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698